3-115663790-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000393780.3(GAP43):c.12C>T(p.Ser4=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0021 in 1,551,722 control chromosomes in the GnomAD database, including 70 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 38 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 32 hom. )
Consequence
GAP43
ENST00000393780.3 synonymous
ENST00000393780.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00800
Genes affected
GAP43 (HGNC:4140): (growth associated protein 43) The protein encoded by this gene has been termed a 'growth' or 'plasticity' protein because it is expressed at high levels in neuronal growth cones during development and axonal regeneration. This protein is considered a crucial component of an effective regenerative response in the nervous system. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 3-115663790-C-T is Benign according to our data. Variant chr3-115663790-C-T is described in ClinVar as [Benign]. Clinvar id is 784015.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.008 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0108 (1640/152336) while in subpopulation AFR AF= 0.0375 (1558/41576). AF 95% confidence interval is 0.0359. There are 38 homozygotes in gnomad4. There are 766 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1640 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GAP43 | NM_002045.4 | c.31-12223C>T | intron_variant | ENST00000305124.11 | |||
GAP43 | NM_001130064.2 | c.12C>T | p.Ser4= | synonymous_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GAP43 | ENST00000393780.3 | c.12C>T | p.Ser4= | synonymous_variant | 2/4 | 1 | |||
GAP43 | ENST00000305124.11 | c.31-12223C>T | intron_variant | 1 | NM_002045.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0107 AC: 1624AN: 152218Hom.: 37 Cov.: 32
GnomAD3 genomes
AF:
AC:
1624
AN:
152218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00253 AC: 396AN: 156676Hom.: 10 AF XY: 0.00198 AC XY: 164AN XY: 83014
GnomAD3 exomes
AF:
AC:
396
AN:
156676
Hom.:
AF XY:
AC XY:
164
AN XY:
83014
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00116 AC: 1618AN: 1399386Hom.: 32 Cov.: 31 AF XY: 0.00103 AC XY: 712AN XY: 690196
GnomAD4 exome
AF:
AC:
1618
AN:
1399386
Hom.:
Cov.:
31
AF XY:
AC XY:
712
AN XY:
690196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0108 AC: 1640AN: 152336Hom.: 38 Cov.: 32 AF XY: 0.0103 AC XY: 766AN XY: 74488
GnomAD4 genome
AF:
AC:
1640
AN:
152336
Hom.:
Cov.:
32
AF XY:
AC XY:
766
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at